UK markets closed

MGNX Jul 2024 2.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.30000.0000 (0.00%)
As of 02:41PM EDT. Market open.
Full screen
Previous close0.3000
OpenN/A
Bid0.0000
Ask0.7500
Strike2.50
Expiry date2024-07-19
Day's range0.3000 - 0.3000
Contract rangeN/A
VolumeN/A
Open interest56
  • GlobeNewswire

    MacroGenics to Participate in Upcoming Investor Conference

    ROCKVILLE, MD, June 11, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conference this month: Goldman Sachs 45th Annual Global Healthcare Conference (Miami Beach). MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., P

  • Simply Wall St.

    Shareholders in MacroGenics (NASDAQ:MGNX) are in the red if they invested three years ago

    This month, we saw the MacroGenics, Inc. ( NASDAQ:MGNX ) up an impressive 37%. But that doesn't change the fact that...

  • GlobeNewswire

    MacroGenics to Participate in Upcoming Investor Conferences

    ROCKVILLE, MD, May 13, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences this month: The Citizens JMP Life Sciences Conference (New York). MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., Ph.D., will parti